{"id":"https://openalex.org/W2261826041","doi":"https://doi.org/10.1093/oxfordjournals.annonc.a059108","title":"Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors","display_name":"Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors","publication_year":1995,"publication_date":"1995-02-01","ids":{"openalex":"https://openalex.org/W2261826041","doi":"https://doi.org/10.1093/oxfordjournals.annonc.a059108","mag":"2261826041","pmid":"https://pubmed.ncbi.nlm.nih.gov/7786821"},"language":"en","primary_location":{"id":"doi:10.1093/oxfordjournals.annonc.a059108","doi":"https://doi.org/10.1093/oxfordjournals.annonc.a059108","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oxfordjournals.annonc.a059108","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(19)61124-5/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.annalsofoncology.org/article/S0923-7534(19)61124-5/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032321264","display_name":"Gilles Catimel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G. Catimel","raw_affiliation_strings":["Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103854256","display_name":"Guy G. Chabot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G.G. Chabot","raw_affiliation_strings":["Laboratory of Pharmacotoxicology and Pharmacogenetics (CNRS URA-147 and 1NSERM U-140), Institut Gustave-Roussy, Villejuif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacotoxicology and Pharmacogenetics (CNRS URA-147 and 1NSERM U-140), Institut Gustave-Roussy, Villejuif","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110476256","display_name":"Jean\u2010Paul Guastalla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J.P. Guastalla","raw_affiliation_strings":["Department of Medical Oncology and Pharmacology Unit, Centre L\u00e9on B\u00e9rard, Lyon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Pharmacology Unit, Centre L\u00e9on B\u00e9rard, Lyon","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030653205","display_name":"Arlette Dumortier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Dumortier","raw_affiliation_strings":["Department of Medical Oncology and Pharmacology Unit, Centre L\u00e9on B\u00e9rard, Lyon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Pharmacology Unit, Centre L\u00e9on B\u00e9rard, Lyon","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Cote","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4399657954","display_name":"Laboratoire Babel","ror":"https://ror.org/00sg8gh54","country_code":"FR","type":"facility","lineage":["https://openalex.org/I143002897","https://openalex.org/I4399657954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Cote","raw_affiliation_strings":["Laboratoire Bellon, Neuilly sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire Bellon, Neuilly sur Seine, France","institution_ids":["https://openalex.org/I4399657954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081750608","display_name":"Caroline Engel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Engel","raw_affiliation_strings":["Department of Medical Oncology and Pharmacology Unit, Centre L\u00e9on B\u00e9rard, Lyon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Pharmacology Unit, Centre L\u00e9on B\u00e9rard, Lyon","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114254925","display_name":"Alain Gouyette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Gouyette","raw_affiliation_strings":["Laboratory of Pharmacotoxicology and Pharmacogenetics (CNRS URA-147 and 1NSERM U-140), Institut Gustave-Roussy, Villejuif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacotoxicology and Pharmacogenetics (CNRS URA-147 and 1NSERM U-140), Institut Gustave-Roussy, Villejuif","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060678091","display_name":"Anne Mathieu-Bou\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4399657954","display_name":"Laboratoire Babel","ror":"https://ror.org/00sg8gh54","country_code":"FR","type":"facility","lineage":["https://openalex.org/I143002897","https://openalex.org/I4399657954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Mathieu-Bou\u00e9","raw_affiliation_strings":["Laboratoire Bellon, Neuilly sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire Bellon, Neuilly sur Seine, France","institution_ids":["https://openalex.org/I4399657954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033328090","display_name":"Monder Mahjoubi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4399657954","display_name":"Laboratoire Babel","ror":"https://ror.org/00sg8gh54","country_code":"FR","type":"facility","lineage":["https://openalex.org/I143002897","https://openalex.org/I4399657954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Mahjoubi","raw_affiliation_strings":["Laboratoire Bellon, Neuilly sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire Bellon, Neuilly sur Seine, France","institution_ids":["https://openalex.org/I4399657954"]}]},{"author_position":"last","author":{"id":null,"display_name":"M. Clavel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Clavel","raw_affiliation_strings":["Department of Medical Oncology and Pharmacology Unit, Centre L\u00e9on B\u00e9rard, Lyon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Pharmacology Unit, Centre L\u00e9on B\u00e9rard, Lyon","institution_ids":["https://openalex.org/I4210105738"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":4.3631,"has_fulltext":true,"cited_by_count":111,"citation_normalized_percentile":{"value":0.95678175,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"6","issue":"2","first_page":"133","last_page":"140"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9900000095367432},{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.8209999799728394},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8479999899864197},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9649999737739563},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8190000057220459},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.9150000214576721},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.9879999756813049},{"id":"https://openalex.org/keywords/refractory-solid-tumors","display_name":"refractory solid tumors","score":0.7850000262260437},{"id":"https://openalex.org/keywords/enterohepatic-circulation","display_name":"enterohepatic circulation","score":0.7850000262260437},{"id":"https://openalex.org/keywords/linear-pharmacokinetics","display_name":"linear pharmacokinetics","score":0.7160000205039978},{"id":"https://openalex.org/keywords/interpatient-variability","display_name":"interpatient variability","score":0.5590000152587891},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7099999785423279},{"id":"https://openalex.org/keywords/cumulative-toxicity","display_name":"cumulative toxicity","score":0.4480000138282776},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.6830000281333923},{"id":"https://openalex.org/keywords/chemotherapy-schedule","display_name":"chemotherapy schedule","score":0.4309999942779541},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.4269999861717224},{"id":"https://openalex.org/keywords/total-body-clearance","display_name":"body clearance","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.9170668721199036},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.8592439889907837},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8471297025680542},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.6144489049911499},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.5164592266082764},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5130199790000916},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5123807191848755},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5036634802818298},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4914759397506714},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48224884271621704},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4801884889602661},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.4551132321357727},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.4461202323436737},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41303133964538574},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.07806867361068726},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.061080604791641235}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000505","descriptor_name":"Alopecia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007970","descriptor_name":"Leukopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/oxfordjournals.annonc.a059108","doi":"https://doi.org/10.1093/oxfordjournals.annonc.a059108","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oxfordjournals.annonc.a059108","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(19)61124-5/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},{"id":"pmid:7786821","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7786821","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of oncology : official journal of the European Society for Medical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1093/oxfordjournals.annonc.a059108","doi":"https://doi.org/10.1093/oxfordjournals.annonc.a059108","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oxfordjournals.annonc.a059108","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(19)61124-5/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320327436","display_name":"Yakult Honsha","ror":"https://ror.org/03wmnrc91"},{"id":"https://openalex.org/F4320330962","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2261826041.pdf","grobid_xml":"https://content.openalex.org/works/W2261826041.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W37120966","https://openalex.org/W106814647","https://openalex.org/W1480716635","https://openalex.org/W1502025781","https://openalex.org/W1506819196","https://openalex.org/W1536538430","https://openalex.org/W1541204074","https://openalex.org/W1549846058","https://openalex.org/W1567663060","https://openalex.org/W1663737385","https://openalex.org/W1755629647","https://openalex.org/W1794341310","https://openalex.org/W1850727413","https://openalex.org/W1903533038","https://openalex.org/W1952431753","https://openalex.org/W2001096578","https://openalex.org/W2041996138","https://openalex.org/W2043703023","https://openalex.org/W2078751203","https://openalex.org/W2098822886","https://openalex.org/W2125397490","https://openalex.org/W2152936905","https://openalex.org/W2159921901","https://openalex.org/W2167805334","https://openalex.org/W2169186295","https://openalex.org/W2246769930","https://openalex.org/W2410665454","https://openalex.org/W2413694431","https://openalex.org/W2419655738","https://openalex.org/W4233567369","https://openalex.org/W6601512586","https://openalex.org/W6630351031","https://openalex.org/W6638372444","https://openalex.org/W6639049465","https://openalex.org/W6714496538"],"related_works":["https://openalex.org/W2246769930","https://openalex.org/W2125739525","https://openalex.org/W1774923611","https://openalex.org/W2069494336","https://openalex.org/W2104027625","https://openalex.org/W1663737385","https://openalex.org/W1894737231","https://openalex.org/W2308212596","https://openalex.org/W2311628233","https://openalex.org/W2071351256"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}